Apnimed, Inc. funding

Apnimed, Inc., a pharmaceuticals company based in Cambridge, MA, filed a Form D with the SEC on March 27, 2026 and reported $25M raised.

Amount raised$25M

Offering size$25M

Filed with the SECMarch 27, 2026

First saleMarch 11, 2026

IndustryPharmaceuticals

SecuritiesEquity

LocationCambridge, MA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far2

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 27

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care